T. Klein

Pharmacology · 2005

A researcher in the Science corpus: 1 paper; trusts 7 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom T. Klein trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Allyn C. Howlett
  2. Daniele Piomelli
  3. Shizuo Akira
  4. M. Guzmán
  5. Howard L. Weiner

Who trusts T. Klein overall

  1. V. Di Marzo
  2. P. Pacher
  3. E. Groce

Papers from T. Klein's perspective

Ordered by how strongly the researchers T. Klein trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The molecular logic of endocannabinoid signalling (Nature Reviews Neuroscience)
  2. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (Proceedings of the National Academy of Sciences of the United States of America)
  3. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. (Proceedings of the National Academy of Sciences of the United States of America)
  4. International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors (Pharmacological Reviews)
  5. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury (Nature)
  6. Toll-like receptor signalling (Nature reviews. Immunology)
  7. Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration (Journal of Neuroscience)
  8. Cannabinoid physiology and pharmacology: 30 years of progress. (Neuropharmacology)
  9. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. (The Lancet)
  10. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses (Nature)

Their papers